Literature DB >> 11943957

Management of Lithuanian children's acute diarrhoea with Gastrolit solution and dioctahedral smectite.

Irena Narkeviciute1, Odilija Rudzeviciene, Giedra Leviniene, Kristina Mociskiene, Rimantas Eidukevicius.   

Abstract

OBJECTIVE: Acute gastroenteritis represents a major cause of morbidity and mortality worldwide among children, and rehydration treatment has been one of the cornerstones in the management strategy. The natural clay dioctahedral smectite (Smecta) increases intestinal barrier function and is effective against infectious diarrhoea in children. The purpose of this work was to compare the efficacy and tolerance of Lithuanian children's diarrhoea treatment with dioctahedral smectite combined with hypotonic oral rehydration solution (ORS)--Gastrolit--versus Gastrolit alone to establish the influence of Smecta on serum electrolyte balance in young children with diarrhoea and mild or moderate dehydration.
METHODS: Smecta combined with ORS (study group) and ORS alone (control group) were evaluated in a multicentre, open, randomized trial in 54 children aged 6-48 months hospitalized for acute diarrhoea (mostly rotavirus aetiology) and signs of mild and moderate dehydration. The main outcomes examined were duration of diarrhoea, fever, number of vomiting episodes, and serum electrolyte balance before and after treatment.
RESULTS: The mean duration of diarrhoea was significantly shorter in the study group (42.3 +/- 24.7 h) than in the control group (61.8 +/- 33.9 h). No side effects of Smecta were observed. The changes of sodium, potassium, chloride and calcium concentrations after treatment were minimal and in the normal range.
CONCLUSIONS: Smecta significantly reduced the duration of diarrhoea, was safe and well tolerated, and had no impact on the adsorption of electrolytes. Smecta could be used together with ORS in children suffering from acute gastroenteritis (without uncontrollable vomiting) with mild and moderate dehydration.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11943957     DOI: 10.1097/00042737-200204000-00015

Source DB:  PubMed          Journal:  Eur J Gastroenterol Hepatol        ISSN: 0954-691X            Impact factor:   2.566


  5 in total

Review 1.  Best evidence topic report. Smectite for acute diarrhoea in children.

Authors:  Zui-Shen Yen; Mei-Shu Lai
Journal:  Emerg Med J       Date:  2006-01       Impact factor: 2.740

Review 2.  Chapter 11.6 Clays and Clay Minerals as Drugs.

Authors:  M T Droy-Lefaix; F Tateo
Journal:  Dev Clay Sci       Date:  2007-09-04

Review 3.  The Role of Purported Mucoprotectants in Dealing with Irritable Bowel Syndrome, Functional Diarrhea, and Other Chronic Diarrheal Disorders in Adults.

Authors:  Carmen Alonso-Cotoner; Mar Abril-Gil; Mercé Albert-Bayo; John-P Ganda Mall; Elba Expósito; Ana M González-Castro; Beatriz Lobo; Javier Santos
Journal:  Adv Ther       Date:  2021-03-18       Impact factor: 3.845

Review 4.  Smectite for acute infectious diarrhoea in children.

Authors:  Giordano Pérez-Gaxiola; Carlos A Cuello-García; Ivan D Florez; Víctor M Pérez-Pico
Journal:  Cochrane Database Syst Rev       Date:  2018-04-25

Review 5.  Anti-diarrheal effects of diosmectite in the treatment of acute diarrhea in children: a review.

Authors:  Christophe Dupont; Bernard Vernisse
Journal:  Paediatr Drugs       Date:  2009       Impact factor: 3.022

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.